93 related articles for article (PubMed ID: 1878719)
1. Haemostatic changes in uncomplicated bone marrow transplants.
Collins P; Jones B; Uthayakumar S; Pocock C; Jupp R; Gutteridge G; Chopra R; Blare S; Newland A
Bone Marrow Transplant; 1991; 7 Suppl 2():54. PubMed ID: 1878719
[No Abstract] [Full Text] [Related]
2. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.
Bazarbachi A; Scrobohaci ML; Gisselbrecht C; Marolleau JP; Mansi A; Brice P; Gorra P; Drouet L
Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):135-40. PubMed ID: 8332449
[TBL] [Abstract][Full Text] [Related]
3. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
Ozkaynak MF; Weinberg K; Kohn D; Sender L; Parkman R; Lenarsky C
Bone Marrow Transplant; 1991 Jun; 7(6):467-74. PubMed ID: 1908340
[TBL] [Abstract][Full Text] [Related]
4. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
[TBL] [Abstract][Full Text] [Related]
5. [Whole body irradiation in the conditioning of bone marrow transplantation. Current indications and limiting factors].
Ganem G; Cosset JM; Le Bourgeois JP
Ann Med Interne (Paris); 1989; 140(5):387-92. PubMed ID: 2688510
[No Abstract] [Full Text] [Related]
6. Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Klingemann HG; Shepherd JD; Reece DE; Barnett MJ; Nantel SH; Sutherland HJ; Spinelli JJ; Phillips GL
Bone Marrow Transplant; 1994; 14 Suppl 4():S14-8. PubMed ID: 7728119
[No Abstract] [Full Text] [Related]
7. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
8. [Whole body irradiation].
Le Bourgeois JP; Ganem G
Pathol Biol (Paris); 1989 Feb; 37(2):156-8. PubMed ID: 2652070
[No Abstract] [Full Text] [Related]
9. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
Copelan EA; Biggs JC; Szer J; Thompson JM; Crilley P; Brodsky I; Klein JL; Kapoor N; Harman GS; Avalos BR
Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
[TBL] [Abstract][Full Text] [Related]
10. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
Parquet N; Devergie A; Socié G; Ribaud P; Espérou H; Gluckman E
Ann Med Interne (Paris); 1997; 148(2):132-5. PubMed ID: 9238437
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies.
Ringdén O; Ruutu T; Remberger M; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Ljungman P
Transplant Proc; 1994 Jun; 26(3):1831-2. PubMed ID: 8030160
[No Abstract] [Full Text] [Related]
12. Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.
Brodsky I; Biggs JC; Szer J; Crilley P; Atkinson K; Downs K; Dodds A; Concannon AJ; Avalos BR; Tutschka P
Semin Oncol; 1993 Aug; 20(4 Suppl 4):27-31; quiz 32. PubMed ID: 8342072
[TBL] [Abstract][Full Text] [Related]
13. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers.
Scrobohaci ML; Drouet L; Monem-Mansi A; Devergie A; Baudin B; D'Agay MF; Gluckman E
Thromb Res; 1991 Sep; 63(5):509-19. PubMed ID: 1755004
[TBL] [Abstract][Full Text] [Related]
14. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings.
Mehta J; Powles R; Horton C; Milan S; Singhal S; Treleaven J
Bone Marrow Transplant; 1995 Jun; 15(6):853-8. PubMed ID: 7581080
[TBL] [Abstract][Full Text] [Related]
15. Hepatic veno-occlusive disease following bone marrow transplantation.
Grandt NC
Oncol Nurs Forum; 1989; 16(6):813-7. PubMed ID: 2687804
[TBL] [Abstract][Full Text] [Related]
16. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation.
Lee JH; Choi SJ; Lee JH; Kim SE; Park CJ; Chi HS; Lee MS; Lee JS; Kim WK; Lee KH
Ann Hematol; 2005 May; 84(5):321-30. PubMed ID: 15580502
[TBL] [Abstract][Full Text] [Related]
17. Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics.
Brice K; Valerie B; Claire G; Valerie M; Yves B; Gilles A; Nathalie B
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):135-43. PubMed ID: 17952879
[TBL] [Abstract][Full Text] [Related]
18. Endothelium and bone marrow transplantation.
Catani L; Gugliotta L; Vianelli N; Nocentini F; Baravelli S; Bandini G; Cirio TM; Tura S
Bone Marrow Transplant; 1996 Feb; 17(2):277-80. PubMed ID: 8640179
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
Catani L; Gugliotta L; Mattioli Belmonte M; Vianelli N; Gherlinzoni F; Miggiano MC; Belardinelli AR; Rosti G; Calori E; Bandini G
Bone Marrow Transplant; 1993 Sep; 12(3):253-9. PubMed ID: 8241985
[TBL] [Abstract][Full Text] [Related]
20. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.
Spitzer TR; Cottler-Fox M; Torrisi J; Cahill R; Greenspan A; Lynch M; Deeg HJ
Bone Marrow Transplant; 1989 Sep; 4(5):559-65. PubMed ID: 2676044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]